Physician profile
Joshua Ross Britt
NPI 1457614414
$26,178.82
in general payments reported to CMS, 2019-2025
44 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,036 · 2020: $2,556 · 2021: $3,099 · 2022: $12K · 2023: $182 · 2024: $1,342 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,765.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $8,726.83 | 2022 | |
| Smith+Nephew, INC. | $5,380.12 | 2019-2025 | Stravix, Bone Anchors With Arthroscopic Delivery System, Grafix Pl |
| Stryker Corporation | $3,792.59 | 2019-2025 | Viaflow, Allowrap, Actishield |
| Integra Lifesciences Corporation | $3,050.61 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Osteomed LLC | $1,697.52 | 2019 | |
| Paratek Pharmaceuticals, INC. | $372.05 | 2023-2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $307.94 | 2019-2021 | |
| Horizon Therapeutics Plc | $297.84 | 2019-2021 | |
| Zyla Life Sciences, INC. | $285.52 | 2019-2020 | |
| Bone Support INC. | $172.43 | 2022 | |
| Innovation Technologies INC | $153.87 | 2020-2025 | Irrisept |
| Access Pro Medical, LLC | $137.06 | 2025 | Matriderm |
| Aroa Biosurgery Incorporated | $136.56 | 2024-2025 | |
| Electronic Waveform Lab, INC. | $130.71 | 2019-2021 | |
| Organogenesis INC. | $124.37 | 2020-2025 | Via Matrix |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $114.87 | 2024-2025 | Acumed, Acumed |
| Carbofix Orthopedics INC | $107.65 | 2019-2022 | |
| Trice Medical, INC. | $100.92 | 2022 | |
| Crossroads Extremity Systems, LLC | $93.07 | 2019 | |
| Orthofix Medical, INC. | $91.55 | 2022 | |
| Theragen, INC. | $91.20 | 2021 | |
| Bioventus LLC | $84.95 | 2019-2023 | Stimrouter Implantable Kit |
| Dynasplint Systems INC. | $60.86 | 2019-2024 | Dynasplint |
| Depuy Synthes Sales INC. | $59.89 | 2021-2025 | Healix Knotless Peek, Dynatape, Dynacord |
| Checkpoint Surgical, INC | $50.63 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $50.42 | 2024-2025 | |
| Radius Health, INC. | $48.36 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $41.95 | 2024-2025 | Exparel, Iovera, Zilretta |
| Flower Orthopedics Coporation | $40.35 | 2023 | |
| Kerecis Limited | $38.29 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Melinta Therapeutics, LLC | $33.16 | 2019 | |
| Nextremity Solutions INC. | $32.98 | 2019 | |
| Amgen INC. | $31.57 | 2025 | Evenity |
| Ermi LLC | $29.02 | 2021 | |
| Averitas Pharma INC. | $28.88 | 2025 | Qutenza |
| Stimwave Technologies Incorporated | $28.51 | 2019-2020 | |
| Highridge Medical LLC | $28.02 | 2024 | Biomet Ebi Bone Healing System |
| Osiris Therapeutics INC. | $27.80 | 2019 | |
| Axogen | $23.69 | 2021 | |
| Abbott Laboratories | $17.69 | 2025 | Eterna |
| Endo Pharmaceuticals INC. | $17.01 | 2019 | |
| Nalu Medical, INC. | $16.08 | 2022 | |
| Providence Medical Technology, INC. | $13.09 | 2019 | |
| Heraeus Medical, LLC. | $10.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Britt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.